Lang & Schwarz
23.03.26 | 22:59
0,028 Euro
-100,00 % -0,028
1-Jahres-Chart
5-Tage-Chart
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 0,022 | 0,034 | 23.03. |
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 21.01. | StageZero Life Sciences Ltd.: StageZero Announces Partial Revocation of Failure to File Cease Trade Order and Proposed Financing | 1 | TheNewswire | ||
| STAGEZERO LIFE SCIENCES Aktie jetzt für 0€ handeln | |||||
| 28.08.25 | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 28.08.2025 | 1.289 | Xetra Newsboard | The following instruments on Boerse Frankfurt do have their last trading day on 28.08.2025.Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 28.08.2025.ISIN NameAU000000DHG9 DOMAIN... ► Artikel lesen |
2 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| CARL ZEISS MEDITEC | 23,420 | -0,51 % | Ihre wichtigsten Termine: Spannende Updates von: Fedex, Continental, Docmorris, Carl Zeiss Meditec und 1&1 | © Foto: Kevin Wolf - FR33460 APGut geplant in den Tag. Mit dem wO-Tagesausblick haben Sie die wichtigsten Termine im Blick und starten bestens vorbereitet in den neuen Handelstag.Unternehmenstermine... ► Artikel lesen | |
| INTUITIVE SURGICAL | 414,65 | +0,29 % | Intuitive Surgical vs. Stryker: Which Surgical Tech Stock Leads? | ||
| BOSTON SCIENTIFIC | 60,20 | -0,66 % | If You Invested $100 In Boston Scientific Stock 10 Years Ago, You Would Have This Much Today | ||
| PLUS THERAPEUTICS | 0,247 | 0,00 % | Plus Therapeutics Inc.: Plus Therapeutics to Present New Analysis at ISPOR Showing CNSide May Reduce Leptomeningeal Metastases Healthcare Costs by 40% | ||
| ASENSUS SURGICAL | - | - | GlobalLogic, Asensus ink surgical robotics engineering collab | ||
| LIFEWARD | 6,900 | 0,00 % | Lifeward Ltd.: Lifeward Reports Fourth Quarter and Full Year 2025 Financial Results | Advancing transformation into a diversified biomedical innovation company with a clear path to cash flow positive Oramed strategic transaction receives shareholder approval- Lifeward gains new... ► Artikel lesen | |
| SENSEONICS | 5,450 | -2,68 % | Senseonics Holdings, Inc. Reports Fourth Quarter and Full Year 2025 Financial Results | Generated Q4 revenue of $14.3 million, an increase of 72% year-over-year Received CE Mark approval for commercialization of Eversense 365 in Europe Launched first Eversense 365 AID system integration... ► Artikel lesen | |
| EKSO BIONICS | 10,640 | 0,00 % | Applied Digital Corporation: Applied Digital to Spin Out Cloud Business, Proposes Business Combination with EKSO to Launch ChronoScale | DALLAS, Dec. 29, 2025 (GLOBE NEWSWIRE) -- Applied Digital (NASDAQ: APLD), a designer, builder, and operator of high-performance, sustainably engineered data centers and colocation services for artificial... ► Artikel lesen | |
| IMUNON | 2,280 | -1,72 % | Imunon erweitert At-the-Market-Offering um 7 Millionen US-Dollar | ||
| ROCKWELL MEDICAL | 0,875 | -0,40 % | Why Is Rockwell Medical Gaining Tuesday? | ||
| MEMPHASYS | 0,003 | 0,00 % | Memphasys says Middle East operations unaffected | ||
| VIRIDIAN THERAPEUTICS | 23,340 | -0,26 % | Viridian Therapeutics stellt auf TD Cowen Konferenz Strategie für TED-Behandlung vor | ||
| SINTX TECHNOLOGIES | 2,550 | +2,41 % | SINTX Technologies, Inc.: SINTX Technologies Provides Corporate Business Update Highlighting First Human Implant, Strategic Transformation, and Commercial Execution | Clinical milestone, new President appointment, and platform expansion position SINTX for commercial rollout and revenue growth in 2026 SALT LAKE CITY, Utah, March 23, 2026 (GLOBE NEWSWIRE) -- SINTX... ► Artikel lesen | |
| AXE COMPUTE | 1,060 | 0,00 % | Axe Compute Inc: Axe Compute Appoints Two Technology and Telecom Luminaries to Board of Directors as Company Accelerates AI Infrastructure Strategy | ||
| AETHLON MEDICAL | 2,170 | +0,46 % | AETHLON MEDICAL INC - 8-K, Current Report |
Das Unternehmen STAGEZERO LIFE SCIENCES LTD kann der Branche Gesundheitswesen zugeordnet werden. Die relative Kursveränderung beträgt aktuell -100,00 % bei einem Aktienkurs von 0,028 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu STAGEZERO LIFE SCIENCES LTD finden Sie auf Wallstreet Online.